Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient

EMERYVILLE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. ( AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich’s iconic Z11 molecule was developed using Amyris’s disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.